No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
USPH240517P100000
- 2.18
- 0.000.00%
15min DelayTrading May 8 09:55 ET
0.00High0.00Low
0.00Open2.18Pre Close0 Volume10 Open Interest100.00Strike Price0.00Turnover66.46%IV-6.57%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry2.18Time Value100Contract SizeAmericanOptions Type-0.3038Delta0.0328Gamma48.03Leverage Ratio-0.2184Theta-0.0074Rho-14.59Eff Leverage0.0561Vega
Intraday
- 5D
- 1D
News
U.S. Physical Therapy, Inc. (NYSE:USPH) Q1 2024 Earnings Call Transcript
US Physical Therapy Is Maintained at Outperform by Barrington Research
US Physical Therapy Is Maintained at Outperform by Barrington Research
Express News | Barrington Research Maintains Outperform on US Physical Therapy, Maintains $122 Price Target
Analysts' Top Healthcare Picks: US Physical Therapy (USPH), Exact Sciences (EXAS)
Buy Rating for US Physical Therapy: Strong Performance and Positive Growth Outlook
Q1 2024 US Physical Therapy Inc Earnings Call
Comments
U.S. Physical Therapy's declining ROCE trend is concerning. Despite reinvestment, returns are shrinking and shareholder returns have been flat over five years. The stock doesn't show multi-bagger traits, suggesting investors may find better options elsewhere.
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal 1
Investors remain optimistic about U.S. Physical Therapy's robust earnings outlook. The market's high P/E ratio reflects strong future growth expectations for the company, despite the industry average.
The cautious investor sentiment towards the company's future is reflected in declining share price and EPS. A potential stabilization is indicated by a 0.7% TSR gain over past year, albeit below market return.
Read more